Dacarbazine
Dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma.
Further indications for dacarbazine as part of combination chemotherapy are:
- advanced Hodgkin’s disease,
- advanced adult soft tissue sarcomas (except mesothelioma, Kaposi sarcoma).
